FIXED-DOSE IRBESARTAN-HYDROCHLOROTHIAZIDE TREATMENT ADHERENCE IN ESSENTIAL HYPERTENSION PATIENTS: REGIONAL, MULTICENTER, NON-INTERVENTIONAL, NON-CONTROLLED, 3 MONTHS COHORT STUDY, PROSPECTIVE REGISTRY IN THE GULF REGION.
Zenodo (CERN European Organization for Nuclear Research)